Skip to main content
. 2019 Nov 29;24(6):1360–1372. doi: 10.1177/1362361319889272

Table 1.

Participant characteristics, demographic information and symptom measures at baseline.

TAU (n = 35) mean (SD), N completed, or n/N completed (%) GSH (n = 35) mean (SD), N completed, or n/N completed (%)
Gender: male 27/35 (77%) 24/34 (69%)
Age in years: mean, SD, n 40.2 (12.6), 28 35.3 (13.6), 29
Ethnicity: White 33/35 (94%) 33/34 (94%)
Accommodation type: owner occupied 11/31 (35%) 14/34 (41%)
Residential status: primary tenant/leaseholder 17/30 (55%) 11/33 (32%)
Education: GCSE and above 28/31 (90%) 33/34 (97%)
Employment status: paid or voluntary employment or training (full- or part-time) 17/32 (53%) 15/33 (45%)
Financial support/stress: moderate/significant financial stress 17/31 (55%) 11/33 (33%)
Relationship status: single 23/31 (74%) 19/34 (56%)
Currently taking other medication for mental health 5/28 (18%) 7/32 (22%)
Experience of psychological/talking therapy: at least one experience 21/29 (75%) 20/29 (70%)
Depression measures
 PHQ-9 score 16.5 (4.8), 35 15.0 (3.2), 35
 BDI-II score 32.0 (11.5), 31 29.9 (8.8), 33
 HAM-D score 17.6 (6.9), 29 17.4 (5.6), 34
 CIS-R score 29.4 (11.0), 35 30.5 (8.6), 34
Depression duration
 Less than 2 weeks 1/24 (4%) 0/28
 Between 2 weeks and 6 months 5/24 (21%) 3/28 (11%)
 Between 6 months and 1 year 3/24 (13%) 1/28 (4%)
 Between 1 and 2 years 0 4/28 (14%)
 Two years or more 15/24 (63%) 20/28 (71%)
CIS-R categories (ICD-10)
 Primary diagnosis
 No diagnosis identified 2/35 (6%) 1/34 (3%)
 Generalised anxiety disorder – mild 0/35 (0%) 1/34 (3%)
 Mixed anxiety and depressive disorder 1/35 (3%) 1/34 (3%)
 Specific (isolated) phobia 2/35 (6%) 0/34 (0%)
 Agoraphobia 1/35 (3%) 0/34 (0%)
 Generalised anxiety disorder 4/35 (11%) 4/34 (12%)
 Panic disorder 2/35 (6%) 1/34 (3%)
 Mild depressive episode 5/35 (14%) 6/34 (18%)
 Moderate depressive episode 13/35 (37%) 16/34 (47%)
 Severe depressive episode 5/35 (14%) 4/34 (12%)
 Secondary diagnosis
 No diagnosis identified 3/35 (9%) 1/34 (3%)
 Mixed anxiety and depressive disorder (mild) 2/35 (6%) 2/34 (6%)
 Mixed anxiety and depressive disorder 12/35 (34%) 7/34 (21%)
 Specific (isolated) phobia 1/35 (3%) 2/34 (6%)
 Social phobia 2/35 (6%) 5/34 (15%)
 Agoraphobia 1/35 (3%) 1/34 (3%)
 Generalised anxiety disorder 12/35 (34%) 12/34 (35%)
 Panic disorder 2/35 (6%) 4/34 (12%)
Other outcome measures
 GAD-7 score 12.9 (4.4), 32 12.4 (4.5), 34
 OCI-R score 31.2 (15.4), 29 29.0 (13.7), 34
 WSAS score 25.8 (8.9), 32 24.8 (7.8), 33
 SF-12 normalised physical function score 43.4 (11.3), 30 41.8 (9.0), 32
 SF-12 normalised mental health score 29.6 (10.0), 30 30.5 (7.0), 32
 EQ-5D-5L score 0.605 (0.210), 31 0.621 (0.214), 33

TAU: treatment as usual; SD: standard deviation; GSH: guided self-help; PHQ-9: Patient Health Questionnaire-9; BDI-II: Beck Depression Inventory-II; CIS-R: Clinical Interview Schedule-Revised; GAD-7: General Anxiety Disorder Questionnaire; OCI-R: Obsessive Compulsive Inventory-Revised; WSAS: Work and Social Adjustment Scale; HAM-D: Hamilton Rating Scale for Depression; GCSE: General Certificate of Secondary Education; SF-12: 12-Item Short Form Health Survey; ICD: International Classification of Diseases.